• 0.75mg (0.25mL) per day, 5 days per week
• Tesamorelin is a growth hormone-releasing hormone (GHRH) analog
• Stimulates your body's own production of growth hormone
• Administered as a subcutaneous injection

Tesamorelin is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH), signaling the pituitary gland to release more of your body's own growth hormone.

A-LIST Tesamorelin Injectable is supplied as a 3mg/mL, 5mL vial (a 1-month supply) and dosed at 0.75mg (0.25mL) subcutaneously once daily, 5 days per week.

A-LIST Tesamorelin Injectable is not for the diagnosis, treatment, cure, or prevention of any disease or medical condition. It may be considered as part of a broader health routine that includes nutrition, exercise, recovery, and other daily practices.

Before a prescription is issued, your medical intake is reviewed by a board-certified physician licensed in your state. If appropriate, the physician will determine whether tesamorelin is a fit for you based on your health history, goals, and applicable medical guidelines.